HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Structural heart disease

How to standardize frailty in aortic stenosis patients

Frailty is the patient’s diminished capacity to recover after pathological or iatrogenic processes. It has a fundamental...
solaci -
Learn More
Coronary disease

Incomplete Revascularization Is Associated with Mortality in TAVR

Courtesy of Dr. Carlos Fava. TAVR has proven to be beneficial for inoperable and high-risk patients, as well as...
solaci -
Learn More
Structural heart disease

Valve Deterioration after TAVI Is Rare and Should Not Prevent Advancement to Younger Populations

Durability ─or better yet, lack of deterioration─ is still a matter of debate when considering transcatheter aortic...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | When is the optimal timing for PCI: before or during TAVI

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Conrad...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | TAVI intermediate risk: Reality or passion?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Flavio...
solaci -
Learn More
Structural heart disease

SOLACI CACI 2017 | Prevention of valvular thrombosis: antiaggregation or anticoagulation?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr....
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | TAVI: Clinical Evidence of long term durability of prosthetic valves

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dra. Carla...
solaci -
Learn More
Day 2

SOLACI CACI 2017 | Clinical evidence of TAVR in intermediate risk patients: Lessons from clinical trials

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Andreas...
solaci -
Learn More